Patient Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-100,000
| Closed | -$2.2M | – | 43 |
|
|
2024
Q4 | $2.2M | Hold |
100,000
| – | – | 0.1% | 38 |
|
|
2024
Q3 | $1.8M | Hold |
100,000
| – | – | 0.09% | 39 |
|
|
2024
Q2 | $1.63M | Hold |
100,000
| – | – | 0.09% | 38 |
|
|
2024
Q1 | $1.41M | Hold |
100,000
| – | – | 0.07% | 39 |
|
|
2023
Q4 | $1.04M | Sell |
100,000
-25,000
| -20% | -$261K | 0.06% | 41 |
|
|
2023
Q3 | $1.28M | Sell |
125,000
-181,054
| -59% | -$1.85M | 0.07% | 39 |
|
|
2023
Q2 | $2.3M | Sell |
306,054
-319,946
| -51% | -$2.41M | 0.13% | 37 |
|
|
2023
Q1 | $5.54M | Sell |
626,000
-206,575
| -25% | -$1.83M | 2.47% | 19 |
|
|
2022
Q4 | $7.59M | Sell |
832,575
-342,425
| -29% | -$3.12M | 3.69% | 6 |
|
|
2022
Q3 | $9.48M | Sell |
1,175,000
-17,950
| -2% | -$145K | 4.73% | 3 |
|
|
2022
Q2 | $8.97M | Buy |
1,192,950
+192,100
| +19% | +$1.44M | 3.97% | 4 |
|
|
2022
Q1 | $9.4M | Buy |
1,000,850
+250,950
| +33% | +$2.36M | 3.18% | 10 |
|
|
2021
Q4 | $6.01M | Buy |
+749,900
| New | +$6.01M | 1.73% | 22 |
|